Healthcare Services

Panuveitis Market Expected to Record Steady Growth and Approach $7.14 Billion by 2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Panuveitis Market Over The Period 2026–2030?

The panuveitis market size has experienced rapid expansion in recent years. It is projected to expand from $4.46 billion in 2025 to $4.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.1%. Historically, this growth can be linked to factors such as restricted knowledge of panuveitis, dependence on traditional corticosteroid treatments, inadequate access to ophthalmology experts, a disjointed treatment framework, and the sluggish uptake of diagnostic imaging technologies.

The panuveitis market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $7.14 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.8%. This expansion during the forecast period is primarily driven by progress in biologics and immunomodulatory medications, the increasing prevalence of autoimmune and infectious eye conditions, the development of teleophthalmology services, rising investments in AI-assisted diagnostic tools, and the broadening of hospital and retail pharmacy distribution channels. Significant trends expected during this period include the wider adoption of targeted biologic therapies, increased application of teleophthalmology and remote monitoring, the integration of AI-based diagnostic solutions for eye inflammation, the evolution of personalized treatment methodologies, and the proliferation of specialized ophthalmology centers.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21244&type=smp

Which Economic Or Industry Drivers Are Impacting The Panuveitis Market?

The increasing incidence of autoimmune conditions is anticipated to boost the expansion of the panuveitis market in the future. These conditions arise when the immune system incorrectly targets and damages the body’s own healthy cells and tissues. The growing prevalence of autoimmune diseases is attributable to a combination of genetic predispositions, environmental factors such as pollution and dietary changes, and increased exposure to specific infections and stressors that can trigger immune system dysregulation. Autoimmune disorders contribute to advancements in panuveitis treatment by driving research into immune system modulation, as many panuveitis cases are related to autoimmune activity. For instance, in May 2023, according to the University of Oxford, a UK-based research university, autoimmune disorders affect 10% of the world’s population, with 13% of women and 7% of males affected. Therefore, the rising prevalence of autoimmune disorders is driving the growth of the panuveitis market.

How Is The Panuveitis Market Divided Into Its Major Segments?

The panuveitis market covered in this report is segmented –

1) By Type: Infectious Panuveitis, Non-Infectious Panuveitis

2) By Treatment: Pharmacological, Surgical, Phototherapy

3) By Route Of Administration: Oral, Intravitreal, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Infectious Panuveitis: Bacterial Panuveitis, Viral Panuveitis, Fungal Panuveitis, Parasitic Panuveitis

2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis, Idiopathic Panuveitis, Drug-Induced Panuveitis

What Industry Trends Are Redefining The Panuveitis Market?

Leading companies within the panuveitis market are concentrating on creating advanced products, like oral TYK2/JAK-1 inhibitors, to secure a competitive edge. These substances are small-molecule immunomodulators designed to obstruct inflammatory signaling pathways through the inhibition of both TYK2 and JAK-1 kinases, consequently lessening cytokine-driven inflammation in the eye. As an illustration, Roivant Sciences, a US-based biopharma company, disclosed encouraging mid-stage clinical results for brepocitinib from its NEPTUNE study concerning non-infectious uveitis (encompassing panuveitis) in April 2024. The medication demonstrated effectiveness in diminishing inflammation and macular edema, was well-tolerated, and presented no novel safety concerns. Concurrently, Alumis, a US biotherapeutic company, commenced dosing in June 2023 for its Phase 2 proof-of-concept ESK-001 trial targeting non-infectious uveitis, including panuveitis; this particular molecule is highly selective, orally bioavailable, and engineered to reduce off-target effects through allosteric TYK2 inhibition.

Who Are The Prominent Organizations Shaping The Panuveitis Market?

Major companies operating in the panuveitis market are Pfizer Inc., AbbVie, Amgen, Mallinckrodt plc, EyePoint Pharmaceuticals Inc., Clearside Biomedical Inc., pSivida Corp., Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Novartis AG, F Hoffmann-La Roche AG, Regeneron Pharmaceuticals Inc, Sanofi S A, Bausch Health Companies Inc, Johnson & Johnson, UCB SA, Aldeyra Therapeutics Inc, Kiora Pharmaceuticals Inc, Lux Biosciences Inc, Aciont Inc, Sirion Therapeutics Inc, EyeGate Pharmaceuticals Inc, Oculis Pharma AG, Alcon Inc, Sun Pharmaceutical Industries Ltd, Aerie Pharmaceuticals Inc.

Read the full panuveitis market report here:

https://www.thebusinessresearchcompany.com/report/panuveitis-global-market-report

What Are The Top-Performing Regions Within The Panuveitis Market?

North America was the largest region in the panuveitis market in 2025. The regions covered in the panuveitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Panuveitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21244&type=smp

Browse Through More Reports Similar to the Global Panuveitis Market 2026, By The Business Research Company

Generalized Anxiety Disorder Global Market Report

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Major Depressive Disorder Global Market Report

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Mental Health Global Market Report

https://www.thebusinessresearchcompany.com/report/mental-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795